Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

ClinicalTrials.gov ID: NCT00003894

Public ClinicalTrials.gov record NCT00003894. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 7:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Thalidomide vs. Placebo for Steroid Dependent or Refractory Chronic Graft vs. Host Disease (cGVHD) IND #42782

Study identification

NCT ID
NCT00003894
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Roswell Park Cancer Institute
Other
Enrollment
36 participants

Conditions and interventions

Eligibility (public fields only)

Age range
3 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 1999
Primary completion
Dec 31, 1999
Completion
May 31, 2002
Last update posted
Mar 6, 2011

1999 – 2002

United States locations

U.S. sites
10
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202-3591
University of Kansas Medical Center Kansas City Kansas 66160-7357
Louisiana State University School of Medicine New Orleans Louisiana 70112-2822
Roswell Park Cancer Institute Buffalo New York 14263-0001
Simmons Cancer Center - Dallas Dallas Texas 75235-9154
Brooke Army Medical Center Fort Sam Houston Texas 78234
Cook Children's Medical Center - Fort Worth Fort Worth Texas 76104
University of Texas - MD Anderson Cancer Center Houston Texas 77030
Cancer Center of the Medical College of Wisconsin Milwaukee Wisconsin 53226
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003894, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2011 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003894 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →